Sign in

CIK 0001817713

  • Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822289112
Phone
+1 858-751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-05 RA CAPITAL MANAGEMENT, L.P. Director Purchase +304,287 $30.56 $9.3M 9,621,533
2025-03-05 RA CAPITAL MANAGEMENT, L.P. Director Purchase +37,455 $31.30 $1.2M 9,658,988
2025-03-03 Meyer Andrew Hollman Chief Business Officer Option exercise 10b5-1 +3,334 $4.21 $14K 85,473
2025-03-03 Meyer Andrew Hollman Chief Business Officer Sale 10b5-1 −2,433 $31.88 $78K 83,040
2025-03-03 Meyer Andrew Hollman Chief Business Officer Sale 10b5-1 −901 $32.85 $30K 82,139
2025-03-03 Meyer Andrew Hollman Chief Business Officer Option exercise · Stock Option (right to buy) 10b5-1 −3,334 93,999
2025-02-03 Meyer Andrew Hollman Chief Business Officer Option exercise 10b5-1 +3,334 $4.21 $14K 85,473
2025-02-03 Meyer Andrew Hollman Chief Business Officer Sale 10b5-1 −2,418 $42.08 $102K 83,055
2025-02-03 Meyer Andrew Hollman Chief Business Officer Sale 10b5-1 −816 $42.77 $35K 82,239
2025-02-03 Meyer Andrew Hollman Chief Business Officer Sale 10b5-1 −100 $43.60 $4K 82,139
2025-02-03 Meyer Andrew Hollman Chief Business Officer Option exercise · Stock Option (right to buy) 10b5-1 −3,334 97,333
2025-01-07 Campbell David Alan President and CEO Sale 10b5-1 −5,000 $60.00 $300K 293,054
2025-01-02 McIver Zachariah Chief Medical Officer Grant or award +26,000 26,000
2025-01-02 McIver Zachariah Chief Medical Officer Grant or award · Stock option (right to buy) +91,000 91,000
2025-01-02 Winter Charles M. Chief Technical Officer Grant or award +23,000 77,288
2025-01-02 Winter Charles M. Chief Technical Officer Grant or award · Stock option (right to buy) +80,500 80,500
2025-01-02 Campbell David Alan President and CEO Grant or award +81,000 298,054
2025-01-02 Campbell David Alan President and CEO Grant or award · Stock option (right to buy) +283,500 283,500
2025-01-02 Robinson Byron Chief Strategy Officer Grant or award +28,000 28,000
2025-01-02 Robinson Byron Chief Strategy Officer Grant or award · Stock option (right to buy) +98,000 98,000

Page 5 of 15 · 294 trades